These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25694313)

  • 21. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sample size considerations for superiority trials in systemic lupus erythematosus (SLE).
    Moore AD; Joseph L
    Lupus; 1999; 8(8):612-9. PubMed ID: 10568897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sample size calculations in randomised trials: mandatory and mystical.
    Schulz KF; Grimes DA
    Lancet; 2005 Apr 9-15; 365(9467):1348-53. PubMed ID: 15823387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials.
    Chen H; Zhang N; Lu X; Chen S
    Clin Trials; 2013 Aug; 10(4):522-9. PubMed ID: 23794405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing the sample size during clinical trials with t-distributed test statistics without inflating the type I error rate.
    Timmesfeld N; Schäfer H; Müller HH
    Stat Med; 2007 May; 26(12):2449-64. PubMed ID: 17080491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review.
    McKeown A; Gewandter JS; McDermott MP; Pawlowski JR; Poli JJ; Rothstein D; Farrar JT; Gilron I; Katz NP; Lin AH; Rappaport BA; Rowbotham MC; Turk DC; Dworkin RH; Smith SM
    J Pain; 2015 Mar; 16(3):199-206.e1-7. PubMed ID: 25481494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
    Karrison TG; Maitland ML; Stadler WM; Ratain MJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1455-61. PubMed ID: 17895472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?
    Celik S; Yazici Y; Yazici H
    Eur J Clin Invest; 2014 Nov; 44(11):1034-44. PubMed ID: 25207845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accounting for twin births in sample size calculations for randomised trials.
    Yelland LN; Sullivan TR; Collins CT; Price DJ; McPhee AJ; Lee KJ
    Paediatr Perinat Epidemiol; 2018 Jul; 32(4):380-387. PubMed ID: 29727020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of continuous versus dichotomous outcome variables on study power when sample sizes of orthopaedic randomized trials are small.
    Bhandari M; Lochner H; Tornetta P
    Arch Orthop Trauma Surg; 2002 Mar; 122(2):96-8. PubMed ID: 11880910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of underpowered randomized clinical trials in rheumatology.
    Keen HI; Pile K; Hill CL
    J Rheumatol; 2005 Nov; 32(11):2083-8. PubMed ID: 16265683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, analysis and presentation of factorial randomised controlled trials.
    Montgomery AA; Peters TJ; Little P
    BMC Med Res Methodol; 2003 Nov; 3():26. PubMed ID: 14633287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large sample tests for binary outcomes in fixed-dose combination drug studies.
    Wang SJ; Hung HM
    Biometrics; 1997 Jun; 53(2):498-503. PubMed ID: 9192448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.